Also from their website, an update to shareholders:
Dear Investor,
It’s now official. We have received the approved contract with the Commonwealth of Kentucky Governor’s Office for Technology (GOT) to develop and test our provisionally-patented Verified Prescription SafeguardsTM System in a two-county pilot project through a grant from the Harold Rogers Prescription Drug Diversion Monitoring Fund of the U.S. Department of Justice Bureau of Justice Assistance.
From this point forward, any public statements we make regarding the pilot must be approved by GOT, and will be issued as a news release. As such, you should not expect any regular “fireside chats” in this space. Please refer to our “In the News” page for any relevant updates as they are available. And please do not consider the lack of news a sign of no progress. We are now in a delicate and fundamental stage of our business plan. The successful outcome of the pilot is critical to our success, and we will do nothing to jeopardize this stage.
This has been a long road, but many more milestones lie ahead until we reach our goal. We thank each and every one of our loyal and supportive shareholders who have kept the faith, stayed the course, and — we firmly believe — will be justly and amply rewarded.
Very best regards,
Best wishes,
James Kemper Millard
President & Chief Executive Officer
Equity Technologies & Resources, Inc.
325 West Main Street, Suite 240
Post Office Box 12012
Lexington, Kentucky 40579
VOX: 859.268.4446
eFAX: 419.821.3646
This communication may contain forward-looking statements. The Company expressly disclaims any intent or obligation to update any forward-looking statements.
Verified Prescription Safeguards, VeriScrip, and VPS are trademarks of Verified Prescription Safeguards, Inc., a wholly owned subsidiary of Equity Technologies & Resources, Inc. Envoii is a trademark of Envoii, Inc. |
